Clene Inc. CLNN
- CNM-Au8 — Amyotrophic Lateral Sclerosis NDA Submitted
- CNM-Au8 — Multiple Sclerosis Phase 2
- CNM-Au8 — Parkinson's Disease Phase 2
NAD+ (1 companies · 3 programs)
Companies with an active program directed at NAD+.
Companies with an active program directed at NAD+.